Evidence map›Paper›PMID 31554912›Full record

ArticleScientific reports2019

Impact of conjugation strategies for targeting of antibodies in gold nanoparticles for ultrasensitive detection of 17β-estradiol.

Jairo Pinto Oliveira, Adilson Ribeiro Prado, Wanderson Juvencio Keijok, Paulo Wagnner Pereira Antunes, Enrique Ronald Yapuchura, Marco Cesar Cunegundes Guimarães

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 148 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jairo Pinto OliveiraFederal University of Espirito Santo, Av Marechal Campos1468, Vitoria, ES 29.040-090, Brazil.
Adilson Ribeiro PradoFederal Institute of Espírito Santo, km 6.5 ES 010, Serra, ES 29173-087, Brazil.
Wanderson Juvencio KeijokFederal University of Espirito Santo, Av Marechal Campos1468, Vitoria, ES 29.040-090, Brazil.
Paulo Wagnner Pereira AntunesFederal University of Espirito Santo, Av. Fernando Ferrari, Vitoria, ES, 29075-910, Brazil.
Enrique Ronald YapuchuraFederal University of Espirito Santo, Av. Fernando Ferrari, Vitoria, ES, 29075-910, Brazil.
Marco Cesar Cunegundes GuimarãesFederal University of Espirito Santo, Av Marechal Campos1468, Vitoria, ES 29.040-090, Brazil. jairo.oliveira@ufes.br.
Universidade Federal do Espírito Santo · BRInstituto Federal do Espírito Santo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibody-coated nanoparticles have recently attracted considerable attention, with the focus falling on diagnostics. Nevertheless, controlled antibody bioconjugation remains a challenge. Here, we present two strategies of bioconjugation with the aim of evaluating the best approach for the coupling of antibodies on the surface of nanomaterials in an oriented way. We employed electrostatic interaction (physical adsorption) and covalent conjugation in the orientation of antibodies on the metallic surface as coupling methods, and their influence on the detection of 17β-estradiol was addressed with localized surface plasmon resonance. The understanding of these mechanisms is fundamental for the development of reproducible inorganic bioconjugates with oriented surface as well sensibility of immunoassays.

Indexed as

GoldMetal NanoparticlesAntibodiesChromatography, High Pressure LiquidEstradiolImmunohistochemistryMicroscopy, Electron, TransmissionStatic ElectricitySurface Plasmon ResonanceAntibodiesEstradiolGold

Identifiers

PMID31554912
PMCPMC6761283
OpenAlexW2976254154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.